Unum GroupStrong premium growth, favorable claims, robust sales, aggressive capital returns, and earnings growth outpacing industry; analyst price target implies upside.

Unum Group shares have gained 16.8% over the past year, outpacing the industry's 15.4% growth and closing Wednesday at $91.62, just shy of a 52-week high of $93.22. The stock is supported by strong premium growth, favorable disability claims, robust sales momentum, and aggressive capital returns, with earnings growing 10.6% over five years versus the industry's 0.6%. Based on 13 analysts, the Zacks average price target is $96.77, implying a 5.6% upside, while the stock trades at a price-to-book of 1.34, below the industry's 1.73. The Zacks Consensus Estimate for 2026 revenues is $11.9 billion, a 10.3% decline, but EPS is expected to rise 7.8%, with a long-term earnings growth rate of 11.3% exceeding the industry's 9.7%. Despite mixed analyst revisions and risks from competitive pricing and rising expenses, the company's premium growth outlook of 4-7% for 2026 and adjusted operating income per share guidance of $8.60 to $8.90 support a Zacks Rank #3, or Hold, rating.
Unum GroupStrong premium growth, favorable claims, robust sales, aggressive capital returns, and earnings growth outpacing industry; analyst price target implies upside.
Aflac Incorporated
AMERISAFE Inc
Globe Life Inc